Investors should be thankful that Recell Go caused bleh upside SP movement. —Gives them more time to load up before Recell Go demonstrates what it can do in the next earnings report. If earnings look healed, RCEL could reach $30 in a short time. So the focus of Avita should be to reach the low end of annual guidance and to make sure guidance for profitability by Q3 ‘25 remains intact.
Ann: AVITA Medical Announces FDA Approval of RECELL GO, page-35
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
-0.060(2.37%) |
Mkt cap ! $168.2M | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.51 | $2.45 | $478.8K | 192.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 999 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.51 | 348 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |